Clinical studies have been reported IL6 protein as a regulator that associate with many types of cancers such as multiple myeloma, non‒small cell lung adenocarcinoma, prostate cancer, colorectal cancer, renal cell carcinoma, breast cancer, and ovarian cancer [40,41]. This evidence concerns the gene IL6 and ovarian cancer.